BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The Life Raft Group - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://liferaftgroup.org
X-WR-CALDESC:Events for The Life Raft Group
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190820T160000
DTEND;TZID=America/New_York:20190820T170000
DTSTAMP:20260403T143621
CREATED:20190812T150929Z
LAST-MODIFIED:20190906T143456Z
UID:10000038-1566316800-1566320400@liferaftgroup.org
SUMMARY:Informational Webinar on Avapritinib
DESCRIPTION:Informational Webinar on Avapritinib Clinical Trial Program in GIST – presented by Blueprint Medicines\n\nRECAP HERE\n\nTuesday\, August 20\, Blueprint Medicines is working with The Life Raft Group and GIST Support International to host a webinar providing a data update from the registration-enabling NAVIGATOR trial of the investigational treatment avapritinib in patients with PDGFRA Exon 18 mutant GIST and fourth-line GIST. These data were presented at the American Society of Clinical Oncology (ASCO) Annual Meeting on June 1\, 2019. Please see here for the press release summarizing the data and the slides presented at ASCO. \nThe webinar will be held on August 20th beginning at 4:00 p.m.\, Eastern Time (1:00 p.m.\, Pacific Time).  Maria Roche\, Senior Medical Director at Blueprint Medicines\, will provide an overview of the data presented at ASCO and an update on ongoing or planned studies in multiple lines of GIST treatment. We invite patients with GIST and their families to participate in this informational webinar – see details to access the webinar below. \nPlease submit suggested questions that you would like to be addressed during the webinar to patients@blueprintmedicines.com by Thursday\, August 15th.
URL:https://liferaftgroup.org/event/informational-webinar-on-avapritinib/
CATEGORIES:Research,Webcast
ATTACH;FMTTYPE=image/png:https://liferaftgroup.org/wp-content/uploads/2019/08/blueprint-medicines-event.png
END:VEVENT
END:VCALENDAR